Analyst Ratings for Protagonist Therapeutics (PTGX)
PTGX Rating Summary
PTGX Price Target Summary
- Highest: $49.00 (Jefferies)
- Lowest: $35.00 (JMP Securities)
- Average: $40.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$40.33 (+63.6%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$40.33 (+63.6%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/30/2023 | CapitalOne | Tim Chiang | New Coverage | Overweight (N/A) |
N/A (N/A) |
14.08 (24.66) |
75.14% | Details |
| 5/25/2023 | Jefferies » Updated 6/28/2023 |
Roger Song | New Coverage | Buy (N/A) |
49.00 (40.00) |
25.20 (24.66) |
-2.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
